Jefferies Group LLC Heron Therapeutics, Inc. Call Options Transaction History

Jefferies Group LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$2.3 - $6.29 $672,750 - $1.84 Million	-292,500 Closed	0 $0
Q1 2022 Sep 21, 2023	SELL	$4.63 - $9.94 $1.09 Million - $2.33 Million	-234,800 Reduced 44.53%	292,500 $1.67 Million
Q1 2022 May 16, 2022	SELL	$4.63 - $9.94 $1.09 Million - $2.33 Million	-234,800 Reduced 44.53%	292,500 $1.67 Million
Q4 2021 Sep 21, 2023	BUY	$8.35 - $12.6 $4.4 Million - $6.64 Million	527,300 New	527,300 $4.81 Million
Q4 2021 Feb 14, 2022	BUY	$8.35 - $12.6 $4.32 Million - $6.52 Million	517,300 Added 5173.0%	527,300 $4.81 Million
Q1 2020 May 15, 2020	BUY	$10.23 - $24.56 $102,300 - $245,600	10,000 New	10,000 $117,000

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $127M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.